论文部分内容阅读
目的:探讨分析妈富隆治疗无排卵型功血的临床效果。方法:本文选择的研究病例均是无排卵型功血患者,入院进行诊断治疗时间2013年12月-2016年6月,病例总数50例,按照随机数字表法将其等分为例数一样的对照组和研究组,各25例。对照组使用炔诺酮进行治疗,研究组使用妈富隆进行治疗,观察两组患者治疗效果、不良反应发生情况以及完全止血时间,且实施比较检验分析。结果:对照组治疗总有效率为72.0%,不良反应发生率为32.0%,完全止血平均时间为33.28±6.18h;研究组治疗总有效率为92.0%,不良反应发生率为12.0%,完全止血平均时间为20.01±4.24h。通过比较检验,研究组治疗效果、不良反应发生率和完全止血平均时间较对照组而言均比较优,组间数据对比具有统计学意义(P均<0.05)。结论:使用妈富隆治疗无排卵型功血患者,疗效良好且不良反应发生率低,可加快患者康复的速度,临床应用价值和推广价值高。
Objective: To investigate the clinical effect of Marvelon treatment of anovulatory dysfunctional uterine bleeding. Methods: The study cases selected in this study were all patients with anovulatory dysfunctional uterine bleeding. The patients were admitted to the hospital for diagnosis and treatment from December 2013 to June 2016. The total number of cases was 50 and were equally divided according to the random number table Control group and study group, 25 cases each. The control group was treated with norethindrone. The study group was treated with Marvelon to observe the therapeutic effect, adverse reactions and complete hemostasis time of the two groups, and the comparative test was conducted. Results: In the control group, the total effective rate was 72.0%, the adverse reaction rate was 32.0%, the complete hemostasis mean time was 33.28 ± 6.18h; the total effective rate was 92.0%, the adverse reaction rate was 12.0% The average time was 20.01 ± 4.24h. By comparative test, the study group, the treatment effect, the incidence of adverse reactions and complete hemostasis were better than the control group, the data between the two groups were statistically significant (P all <0.05). Conclusion: The use of Marvelon treatment of anovulatory dysfunctional uterine bleeding in patients with good efficacy and low incidence of adverse reactions can speed up the recovery of patients with clinical application and promotion of high value.